Page 356 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 356
Late Breaker ePosters (Cont.)
LP19 EARLY INTRODUCTION OF SUBCUTANEOUS (S.C.)
HEPATITIS B IMMUNOGLOBULIN (HBIG) PROVIDES
EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV)
REINFECTION AFTER LIVER TRANSPLANTATION (TX)
Didier Samuel, Paolo De Simone*, Mauro Salizoni, Antonio D. Pinna,
Umberto Cillo, Fausto Zamboni, David Mutimer, Italy
LP20 SAFETY AND EFFICACY OF ALL-ORAL DAA REGIMENS IN
HIV-HCV COINFECTED CIRRHOTIC PATIENTS FROM THE
PROSPECTIVE ANRS CO13 – HEPAVIH COHORT
Philippe Sogni*, Camille Gilbert, Karine Lacombe, Lionel Piroth,
Eric Rosenthal, Stéphanie Dominguez, Julie Chas, Didier Neau,
Isabelle Poizot-Martin, Anne Gervais Hasenknopf, Philippe Morlat,
Anne Simon, David Zucman, Hugues Aumaitre, Caroline Lascoux-
Combe, Laure Esterle, François Dabis, Linda Wittkop,
Dominique Salmon-Ceron, France
LATE BREAKER ePOSTERS LP21 THE MACROPHAGE ACTIVATION MARKERS SOLUBLE
CD206 AND CD163 PREDICT MORTALITY IN PATIENTS
WITH LIVER CIRRHOSIS AND ACUTE-ON-CHRONIC LIVER
FAILURE (ACLF)
Henning Groenbaek*, Sidsel Rødgaard-Hansen, Niels Kristian Aagaard,
Vicente Arroyo, Søren Moestrup, Elisabet Garcia, Hendrik Vilstrup,
Holger J. Møller, Denmark
LP22 PHASE 1 RESULTS FROM PXS-4728A, A SELECTIVE
SSAO/VAP-1 INHIBITOR, FOR THE TREATMENT OF
NON-ALCOHOLIC STEATOHEPATITIS
Wolfgang Jarolimek*, Brett Charlton, Australia
LP23 DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT
RIBAVIRIN IN PATIENTS WITH HIV-HCV CO-INFECTION:
INTERIM ANALYSIS OF A FRENCH MULTICENTER
COMPASSIONATE USE PROGRAM
Hélène Fontaine*, Karine Lacombe, Catherine Dhiver, Eric Rosenthal,
Sophie Metivier, Teresa Antonini-Michelle, Marc Antoine Valantin,
Laurent Cotte, Julie Botero, Stanislas Harent, Dominique Batisse,
Georges-Philippe Pageaux, Hugues Aumaitre, Stephanie Dominguez,
Victor De Ledinghen, Vincent Leroy, Francois Dabis, Linda Wittkop,
Anne Filipovics, Marie Helene Barlet,Yacia Bennai, Dominique Salmon,
France
356 The International Liver Congress™ 2015 • ILC Programme
LP19 EARLY INTRODUCTION OF SUBCUTANEOUS (S.C.)
HEPATITIS B IMMUNOGLOBULIN (HBIG) PROVIDES
EFFECTIVE PROPHYLAXIS FOR HEPATITIS B VIRUS (HBV)
REINFECTION AFTER LIVER TRANSPLANTATION (TX)
Didier Samuel, Paolo De Simone*, Mauro Salizoni, Antonio D. Pinna,
Umberto Cillo, Fausto Zamboni, David Mutimer, Italy
LP20 SAFETY AND EFFICACY OF ALL-ORAL DAA REGIMENS IN
HIV-HCV COINFECTED CIRRHOTIC PATIENTS FROM THE
PROSPECTIVE ANRS CO13 – HEPAVIH COHORT
Philippe Sogni*, Camille Gilbert, Karine Lacombe, Lionel Piroth,
Eric Rosenthal, Stéphanie Dominguez, Julie Chas, Didier Neau,
Isabelle Poizot-Martin, Anne Gervais Hasenknopf, Philippe Morlat,
Anne Simon, David Zucman, Hugues Aumaitre, Caroline Lascoux-
Combe, Laure Esterle, François Dabis, Linda Wittkop,
Dominique Salmon-Ceron, France
LATE BREAKER ePOSTERS LP21 THE MACROPHAGE ACTIVATION MARKERS SOLUBLE
CD206 AND CD163 PREDICT MORTALITY IN PATIENTS
WITH LIVER CIRRHOSIS AND ACUTE-ON-CHRONIC LIVER
FAILURE (ACLF)
Henning Groenbaek*, Sidsel Rødgaard-Hansen, Niels Kristian Aagaard,
Vicente Arroyo, Søren Moestrup, Elisabet Garcia, Hendrik Vilstrup,
Holger J. Møller, Denmark
LP22 PHASE 1 RESULTS FROM PXS-4728A, A SELECTIVE
SSAO/VAP-1 INHIBITOR, FOR THE TREATMENT OF
NON-ALCOHOLIC STEATOHEPATITIS
Wolfgang Jarolimek*, Brett Charlton, Australia
LP23 DACLATASVIR PLUS SOFOSBUVIR WITH OR WITHOUT
RIBAVIRIN IN PATIENTS WITH HIV-HCV CO-INFECTION:
INTERIM ANALYSIS OF A FRENCH MULTICENTER
COMPASSIONATE USE PROGRAM
Hélène Fontaine*, Karine Lacombe, Catherine Dhiver, Eric Rosenthal,
Sophie Metivier, Teresa Antonini-Michelle, Marc Antoine Valantin,
Laurent Cotte, Julie Botero, Stanislas Harent, Dominique Batisse,
Georges-Philippe Pageaux, Hugues Aumaitre, Stephanie Dominguez,
Victor De Ledinghen, Vincent Leroy, Francois Dabis, Linda Wittkop,
Anne Filipovics, Marie Helene Barlet,Yacia Bennai, Dominique Salmon,
France
356 The International Liver Congress™ 2015 • ILC Programme
